BLISS CHEMICALS - A REPORT

Bliss GVS Pharma extends gains

Bliss GVS Pharma rose 1.13% to Rs 468 at 10:27 IST on BSE, on bagging an order worth Rs 25 crore for supplying anti-malarial drugs for African countries.

The company made this announcement after the trading hours on Tuesday, 13 November 2007.

Meanwhile, BSE Sensex rose 517.56 points or 2.72% to 19,554.65, as worries about the US credit crisis eased after several top US executives reassured investors that the US banking system could withstand shocks from credit-related losses.

On BSE 580 shares were traded in the counter. The scrip had an average daily volume of 4,780 shares in the past one quarter.

The stock hit a high of Rs 480 and touched a low of Rs 453 so far during the day. The stock had a 52-week high of Rs 515 on 31 October 2007 and 52-week low of Rs 35.65 on 15 November 2006.

The small-cap scrip had outperformed the market over the past one month till 13 November 2007, gaining 17.81% compared to the Sensex's declining 0.12%. It had also outperformed the market in the past one quarter, gaining 135.68% compared to Sensex's rise of 26.90%.

The company's current equity is Rs 6.31 crore. Face value per share is Rs 10.

The current price of Rs 468 discounts Q2 September 2007 annualized EPS of Rs 77.46 by a PE multiple of 6.04. Bliss GVS Pharma's net profit rose 4788% to Rs 12.22 crore on 1894% growth in sales to Rs 29.91 crore in Q2 September 2007 over Q2 September 2006.

The company manufactures and distributes soft vaginal pessaries and anal suppositories. It operates in two segments, health care products and pharma products.

Best Regards,
Ramanathan N.S.